Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Dose-Finding Study of Imidafenacin in OAB
NCT00212706Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2001
- Primary completion
- Nov 2002
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of imidafenacin in overactive bladder (OAB) (4 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Total number of urinary incontinence episodes per week. Started Oct 2001; status: completed.
02
Drugs
imidafenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00212706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212706.